Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Otsuka
Pharma
Astellas, Otsuka, Samsung Biologics—Fierce Pharma Asia
Astellas' CLDN18.2 drug cleared the FDA. Otsuka reported positive readout in IgAN. Samsung Bio signed its largest contract to date. Plus more.
Angus Liu
Oct 25, 2024 8:43am
Lilly, Gilead-Yuhan, Leqembi—Fierce Pharma Asia
Oct 18, 2024 8:20am
Otsuka tots up 6-figure unpaid salary for dementia caregivers
Oct 15, 2024 7:15am
Regor, Legend, WuXi—Fierce Pharma Asia
Oct 4, 2024 8:20am
Lundbeck, Otsuka nab Barbara Corcoran for new agitation campaign
Sep 27, 2024 8:56am
Merck, Leqembi, biosecurity—Fierce Pharma Asia
Aug 2, 2024 10:25am
